RSS-Feed abonnieren
DOI: 10.1055/s-2006-941605
A Novel Bromine-Induced Ring Expansion of the Spiroimine Moiety of the Shellfish Toxin Gymnodimine
Publikationsverlauf
Publikationsdatum:
12. Juni 2006 (online)
![](https://www.thieme-connect.de/media/synlett/200610/lookinside/thumbnails/10.1055-s-2006-941605-1.jpg)
Abstract
Treatment of the shellfish toxin gymnodimine with one equivalent of molecular bromine at -78 °C resulted in stereoselective formation of a novel ring-expansion product. Participation of the spiromine unit in this novel bromine-induced ring expansion reaction provides insight into how the reactivity of spiroimine moiety may contribute to the toxicity of this marine biotoxin when activated by the presence of an appropriate environmental electrophile.
Key words
gymnodimine - shellfish toxin - ring expansion
- 1
Seki T.Satake M.Mackenzie L.Kaspar HF.Yasumoto T. Tetrahedron Lett. 1995, 39: 7093 - 2
Stewart M.Blunt JW.Munro MHG.Robinson WT.Hannah DJ. Tetrahedron Lett. 1997, 38: 4889 - 3
Hu TM.Burton IW.Cembella AD.Curtis JM.Quilliam MA.Walter JA.Wright JLC. J. Nat. Prod. 2001, 64: 308 - 4
Chou T.Haino T.Kuramoto M.Uemura D. Tetrahedron Lett. 1996, 37: 4027 - 5
Takada N.Umemura N.Suenaga K.Uemura D. Tetrahedron Lett. 2001, 42: 3495 - 6
Munday R.Towers NR.MacKenzie L.Beuzenberg V.Holland PT.Miles CO. Toxicon 2004, 44: 173 - 7
Gill S.Murphy M.Clausen J.Richards D.Quilliam MA.MacKinnon S.LeBlanc P.Mueller R.Pulido O. NeuroToxicology 2003, 24: 593 - 8
Dragunow M.Trozss M.Brimble MA.Cameron R.Beuzenberg V.Holland P.Mountfort D. Environ. Toxicol. Pharmacol. 2005, 20: 305 - 9
Tehrani KA.Van Syngel K.Boelens M.Contreras J.De Kimpe N.Knight DW. Tetrahedron Lett. 2000, 41: 2507 - 10
De Kimpe N.Boelens M.Piqueur J.Baele J. Tetrahedron 1994, 35: 1925 - 11
Miyano S.Mibu N.Irie M.Sumoto K. Heterocycles 1986, 24: 2121 - 12
Sumoto K.Mibu N.Irie M.Abe N.Miyano S. Chem. Pharm. Bull. 1990, 38: 577 - 14
Miles CO.Wilkins AL.Stirling DJ.MacKenzie AL. J. Agric. Food Chem. 2000, 48: 1373 - 16 For an example of electrophilic activation of a prodrug, see:
Dao V.-T.Dowd MK.Gaspard C.Martin M.-T.Hémez J.Laprévote O.Mayer M.Michelot RJ. Bioorg. Med. Chem. 2003, 11: 2001
References and Notes
Isolation and Purification of Gymnodimine (
1).
Gymnodimine was isolated from a laboratory culture of Karenia selliformis (syn Gymnodinium selliforme CAW D79) at the Cawthron Institute (Nelson, New Zealand). The extraction and purification procedure was based on the reported method, see ref. 14. Prior to passage through an HP-20 resin the culture was acidified with 50% HCl to pH 4.5 and filtered (Toyo GC 90, 124 mm). The toxin was eluted off the HP-20 resin with MeOH, concentrated to low volume and clean-up achieved by solvent partitioning. The purity of the isolated toxin was checked by 600 MHz 1H NMR spectroscopy and LCMS. Two impurities, unknown isomers of gymnodimine, were detected at ca. 4%. The crude extract was further purified by flash column chromatography using CH2Cl2-MeOH-Et3N (10:0.2:0.2) as eluent to obtain a white solid.
Synthesis of Ring-Expansion Product 2. To a solution of gymnodimine (1, 10 mg, 19.7 µmol) in CH2Cl2 (2 mL) was added dropwise a solution of bromine in CH2Cl2 (0.5 M, 44 µL, 22 µmol) at -78 °C and stirring was continued for 5 min. The colourless mixture was warmed to r.t. and directly subjected to flash chromatography (CH2Cl2-MeOH, 85:15). The ring-expansion product 2 (9.7 mg, 81%) was obtained as a colourless wax. R f = 0.44 (CH2Cl2-MeOH, 85:15); [α]D 20 11.3 (CHCl3, c 1.24 g/100 mL). 1H NMR (600 MHz, CDCl3): δ = 1.04 (m, 1 H, 17-Ha), 1.21 (d, J = 7.3 Hz, 3 H, 14-H3), 1.72 (s, 1 H, 21-H3), 1.75 (s, 3 H, 34-H3), 1.76-2.20 (m, 12 H, 4-H2, 5-H2, 15-H2, 17-Hb, 18-H2, 26-H2, 27-Ha), 1.93 (s, 3 H, 32-H3), 2.23 (s, 3 H, 11-H3), 2.51-2.60 (m, 2 H, 13-H, 27-Hb), 2.71 (m, 2 H, 8-H2), 2.87 (m, 1 H, 7-Ha), 3.32 (d, J = 10.4 Hz, 23-H), 3.46 (m, 1 H, 7-Hb), 3.96-4.03 (m, 2 H, 6-Ha, 16-H), 4.19 (m, 2 H, 6-Hb, 19-H), 4.40 (d, J = 6.2 Hz, 1 H, 12-H), 4.93 (dd, J = 8.9, 8.9 Hz, 1 H, 9-H), 5.48 (d, J = 10.6 Hz, 1 H, 22-H), 5.81 (s, 1 H, 28-H), 6.94 (s, 1 H, 33-H). 13C NMR (150 MHz, CDCl3): δ = 10.6 (q, C-32), 11.5 (q, C-21), 17.2 (q, C-34), 18.5 (t, C-26), 20.4 (t, C-4), 21.1 (q, C-14), 22.1 (t, C-18), 25.5 (q, C-11), 26.9 (t, C-8), 30.4 (t, C-27), 31.8 (t, C-5), 32.8 (t, C-7), 34.3 (t, C-17), 35.9 (d, C-13), 40.2 (t, C-15), 45.9 (s, C-3), 48.8 (d, C-23), 51.1 (t, C-6), 66.2 (s, C-10), 77.8 (d, C-16), 79.1 (d, C-19), 79.8 (2 × d, C-9, C-28), 95.6 (d, C-12), 123.8 (d, C-22), 126.4 (s, C-24), 130.7 (s, C-31), 131.7 (s, C-25), 144.9 (s, C-20), 146.7 (d, C-33), 174.3 (s, C-30), 198.5 (s, C-2). IR (film): ν = 3019, 2400, 1755, 1220, 770 cm-1. HRMS: m/z calcd for C32H45 79BrNO4 [MH+ - H2O]: 586.2532; found: 586.2527.